Inhibition of PKC beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy

被引：0
|
作者：
Connelly, Kim A.
Kelly, Darren A.
Zhang, Yuan
Prior, David L.
Krum, Henry
Gilbert, Richard E.
机构：
[1] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia
[2] St Vincents Hosp, Cardiac Invest Unit, Fitzroy, Vic 3065, Australia
[3] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Epidemiol & Prevent Med, NHMRC CCRE Therapeut, Melbourne, Vic, Australia
[4] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Med, NHMRC CCRE Therapeut, Melbourne, Vic, Australia
[5] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：843 / 843
页数：1
相关论文
共 44 条
  • [1] Inhibition of Protein Kinase C-β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy
    Connelly, Kim A.
    Kelly, Darren J.
    Zhang, Yuan
    Prior, David L.
    Advani, Andrew
    Cox, Alison J.
    Thai, Kerri
    Krum, Henry
    Gilbert, Richard E.
    CIRCULATION-HEART FAILURE, 2009, 2 (02) : 129 - 137
  • [2] Inhibition of PKC- preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy
    Li, Zhao
    Abdullah, Chowdhury S.
    Jin, Zhu-Qiu
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (11) : 2913 - 2924
  • [3] Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus
    Nehal N. Mehta
    Matthew Sheetz
    Karen Price
    Lynn Comiskey
    Shirish Amrutia
    Nayyar Iqbal
    Emile R. Mohler
    Muredach P. Reilly
    Cardiovascular Drugs and Therapy, 2009, 23 : 17 - 24
  • [4] Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus
    Mehta, Nehal N.
    Sheetz, Matthew
    Price, Karen
    Comiskey, Lynn
    Amrutia, Shirish
    Iqbal, Nayyar
    Mohler, Emile R.
    Reilly, Muredach P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 17 - 24
  • [5] Inhibition of matrix metalloproteinases reduces streptozotocin-induced diabetic cardiomyopathy
    Sariahmetoglu, Meltem
    Koksoy, Aslihan
    Bilginoglu, Ayca
    Besikci, Arzu
    Turan, Belma
    Schulz, Richard
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S169 - S170
  • [6] Characterization of the role of PKC beta in the regulation of extracellular matrix abnormalities in diabetic rats.
    Koya, D
    Jirousek, MR
    Ishii, H
    King, GL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3139 - A3139
  • [7] Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats
    Wang, Fabin
    Huang, Dong
    Zhu, Wei
    Li, Shuai
    Yan, Meiling
    Wei, Meng
    Li, Jingbo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (05) : 1037 - 1046
  • [8] Matrix metalloproteinase inhibition by gene transfer of TIMP-1 attenuates ventricular remodeling and preserves cardiac function in ischemic cardiomyopathy
    Jayasankar, V
    Bish, LT
    Pirolli, TJ
    Berry, MF
    Burdick, J
    Bhalla, RC
    Sharma, RV
    Gardner, TJ
    Sweeney, HL
    Woo, YJ
    CIRCULATION, 2003, 108 (17) : P - P
  • [9] Intravenous statin administration during myocardial infarction mitigates cardiac damage and preserves cardiac function in diabetic cardiomyopathy rats
    Alcover, Sebastian
    Lopez, Sergi
    Badimon, Lina
    Vilahur, Gemma
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPP 2)
  • [10] The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy
    Dede, Eleni
    Liapis, Dimitrios
    Davos, Constantinos
    Katsimpoulas, Michalis
    Varela, Aimilia
    Mpotis, Ioannis
    Kostomitsopoulos, Nikolaos
    Kadoglou, Nikolaos P. E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 586 : 8 - 13
12345